Eupnoos
London, United Kingdom
Eupnoos is an AI enhanced smartphone app able to use sound to objectively measure lung function in patients diagnosed with chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and interstitial lung disease (ILD). Our platform is the only system that is completely software based and plugs the respiratory disease monitoring gap in the market today. By objectifying and integrating lung function measurements with respiratory symptoms, Eupnoos simplifies self-management through individualised prediction of flare ups as these have the greatest impact on quality of life and healthcare costs. Our vision is to enable cost-effective management of chronic lung conditions with our break-through digital health solution so that physicians can optimize care and patients are empowered to live their best possible lives.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- www.eupnoos.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Eupnoos?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now